Foscavir

Foscavir is a brand name of foscarnet, approved by the FDA in the following formulation(s):

FOSCAVIR (foscarnet sodium - injectable; injection)

• 
  Manufacturer: CLINIGEN HLTHCARE
  
  Approval date: September 27, 1991
  
  Strength(s): 2.4GM/100ML ^[RLD][AP]

Has a generic version of Foscavir been approved?

Yes. The following products are equivalent to Foscavir:

foscarnet sodium injectable; injection

• 
  Manufacturer: HOSPIRA
  
  Approval date: May 31, 2005
  
  Strength(s): 2.4GM/100ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Foscavir. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Foscavir.

See also...

• Foscavir Consumer Information (Wolters Kluwer)
• Foscavir Consumer Information (Cerner Multum)
• Foscavir Advanced Consumer Information (Micromedex)
• Foscavir AHFS DI Monographs (ASHP)
• Foscarnet Consumer Information (Wolters Kluwer)
• Foscarnet Consumer Information (Cerner Multum)
• Foscarnet Intravenous Advanced Consumer Information (Micromedex)
• Foscarnet Sodium AHFS DI Monographs (ASHP)